ALDH5A1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.62447832963153E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
<1E-12 |
Normal-vs-Stage2 |
<1E-12 |
Normal-vs-Stage3 |
1.62447832963153E-12 |
Normal-vs-Stage4 |
1.90958360235527E-12 |
Stage1-vs-Stage2 |
2.235400E-01 |
Stage1-vs-Stage3 |
2.395300E-04 |
Stage1-vs-Stage4 |
2.319000E-01 |
Stage2-vs-Stage3 |
3.316200E-01 |
Stage2-vs-Stage4 |
8.133000E-01 |
Stage3-vs-Stage4 |
6.933200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.62447832963153E-12 |
Normal-vs-AfricanAmerican |
1.69861000000049E-05 |
Normal-vs-Asian |
1.352440E-04 |
Caucasian-vs-AfricanAmerican |
1.683780E-01 |
Caucasian-vs-Asian |
5.781400E-01 |
AfricanAmerican-vs-Asian |
8.231400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.62447832963153E-12 |
Normal-vs-Female |
1.14352971536391E-14 |
Male-vs-Female |
5.774000E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.81817000000084E-05 |
Normal-vs-Age(41-60Yrs) |
1.62458935193399E-12 |
Normal-vs-Age(61-80Yrs) |
1.62447832963153E-12 |
Normal-vs-Age(81-100Yrs) |
3.94018151439468E-13 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.661400E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.093600E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.321800E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.309000E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.276000E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.456600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
8.278000E-02 |
Normal-vs-Grade 2 |
<1E-12 |
Normal-vs-Grade 3 |
1.62447832963153E-12 |
Normal-vs-Grade 4 |
<1E-12 |
Grade 1-vs-Grade 2 |
3.239000E-01 |
Grade 1-vs-Grade 3 |
2.932400E-01 |
Grade 1-vs-Grade 4 |
6.357800E-02 |
Grade 2-vs-Grade 3 |
7.160400E-01 |
Grade 2-vs-Grade 4 |
4.50460000411823E-08 |
Grade 3-vs-Grade 4 |
5.96990000000241E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
<1E-12 |
Normal-vs-ccB subtype |
1.62447832963153E-12 |
ccA subtype-vs-ccB subtype |
1.82947999999294E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.62447832963153E-12 |
Normal-vs-N1 |
1.31360478050624E-11 |
N0-vs-N1 |
1.388360E-01 |
|
|